HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $9 Price Target

Benzinga · 3d ago
HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $9 price target.